Assessing awareness of colorectal cancer symptoms: measure development and results from a population survey in the UK.

Abstract:

BACKGROUND:This paper describes the development of a Cancer Awareness Measure for colorectal (CRC) cancer (Bowel/Colorectal CAMa) (study 1) and presents key results from a population-representative survey using the measure (study 2). METHODS:STUDY 1: Items were taken from the literature and reviewed by expert groups. A series of three validation studies assessed reliability and validity of the measure. To establish test-retest reliability, 49 people over 50 years of age completed the Bowel/Colorectal CAM on two occasions (range 9-14 days, mean 13.5 days). Construct validity was assessed by comparing responses from bowel cancer experts (n = 16) and the lay public (n = 35). Lastly, a brief intervention study tested sensitivity to change with participants (n = 70) randomly allocated to be given a control leaflet or an intervention leaflet and their responses were compared. STUDY 2: 1520 respondents completed the Bowel/Colorectal CAM in a population survey carried out by TNS-British Market Research Bureau International (TNS-BMRB) in March 2010. RESULTS:STUDY 1: Internal reliability (Cronbach's alpha = 0.84) was high. Test-retest reliability was over r = 0.7 for warning signs, risk factors and age people are first invited for screening, but lower (between 0.6 and 0.7) for other items (lifetime risk, awareness of bowel cancer screening, age at risk). Bowel cancer experts achieved higher scores than equally educated controls (54.7 [4.3] vs. 42.9 [5.7]; P < 0.001) demonstrating the measure has construct validity and intervention participants showed higher knowledge than controls (51.4 [5.9] vs. 42.9 [5.7]; P < 0.001) suggesting the measure is sensitive to change. STUDY 2: Respondents recalled on average, one CRC sign and one risk factor. There was particularly low prompted awareness of the signs 'lump in the abdomen' (64%) and 'tiredness' (50%) and several lifestyle risk factors for CRC, e.g. exercise (37%).Respondents from more affluent groups had consistently higher knowledge of signs and risk factors compared to those from more deprived groups. CONCLUSIONS:The Bowel/Colorectal CAM meets accepted psychometric criteria for reliability and construct validity and should therefore provide a useful tool for assessment of CRC awareness. The population survey revealed low awareness of several CRC signs and risk factors and emphasises the importance of continuing public education, particularly about the link between lifestyle behaviours and CRC.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Power E,Simon A,Juszczyk D,Hiom S,Wardle J

doi

10.1186/1471-2407-11-366

subject

Has Abstract

pub_date

2011-08-23 00:00:00

pages

366

issn

1471-2407

pii

1471-2407-11-366

journal_volume

11

pub_type

杂志文章
  • Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies.

    abstract:BACKGROUND:Since most glioblastomas express both wild-type EGFR and EGFRvIII as well as HER2/neu, they are excellent targets for activated T cells (ATC) armed with bispecific antibodies (BiAbs) that target EGFR and HER2. METHODS:ATC were generated from PBMC activated for 14 days with anti-CD3 monoclonal antibody in th...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-83

    authors: Zitron IM,Thakur A,Norkina O,Barger GR,Lum LG,Mittal S

    更新日期:2013-02-22 00:00:00

  • Analysis of genetic copy number changes in cervical disease progression.

    abstract:BACKGROUND:Cervical dysplasia and tumorigenesis have been linked with numerous chromosomal aberrations. The goal of this study was to evaluate 35 genomic regions associated with cervical disease and to select those which were found to have the highest frequency of aberration for use as probes in fluorescent in-situ hyb...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-432

    authors: Policht FA,Song M,Sitailo S,O'Hare A,Ashfaq R,Muller CY,Morrison LE,King W,Sokolova IA

    更新日期:2010-08-16 00:00:00

  • Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.

    abstract:BACKGROUND:Nasopharyngeal carcinoma (NPC) is a type of neoplasm that is highly prevalent in East Asia and Africa with Epstein-Barr virus (EBV), genetic, and dietary factors implicated as possible aetiologic factors. Previous studies suggested the association of certain cytokines with the invasion and metastatic propert...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-574

    authors: Chew MM,Gan SY,Khoo AS,Tan EL

    更新日期:2010-10-22 00:00:00

  • Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma.

    abstract:BACKGROUND:Increased level of serum S100B can serve as a marker of metastatic spread in patients with cutaneous melanoma (CM). In patients with elevated S100 B and/or clinical signs of disease progression PET-CT scan is a valuable tool for discovering metastases and planning treatment.The aims of this study were to det...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-328

    authors: Peric B,Zagar I,Novakovic S,Zgajnar J,Hocevar M

    更新日期:2011-08-02 00:00:00

  • First case of AML with rare chromosome translocations: a case report of twins.

    abstract:BACKGROUND:Leukemia is different from solid tumor by harboring genetic rearrangements that predict prognosis and guide treatment strategy. PML-RARA, RUNX1-RUNX1T1, and KMT2A-rearrangement are common genetic rearrangements that drive the development of acute myeloid leukemia (AML). By contrast, rare genetic rearrangemen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4396-4

    authors: Wang L,Sun Y,Sun Y,Meng L,Xu X

    更新日期:2018-04-23 00:00:00

  • The influence of radiotherapy techniques on the plan quality and on the risk of secondary tumors in patients with pituitary adenoma.

    abstract:BACKGROUND:This planning study compares different radiotherapy techniques for patients with pituitary adenoma, including flatness filter free mode (FFF), concerning plan quality and secondary malignancies for potentially young patients. The flatness filter has been described as main source of photon scatter. MATERIAL ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6535-y

    authors: Treutwein M,Steger F,Loeschel R,Koelbl O,Dobler B

    更新日期:2020-02-03 00:00:00

  • RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.

    abstract:BACKGROUND:Adoptive T-cell therapy relying on conventional T cells transduced with T-cell receptors (TCRs) or chimeric antigen receptors (CARs) has caused substantial tumor regression in several clinical trials. However, genetically engineered T cells have been associated with serious side-effects due to off-target tox...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3539-3

    authors: Harrer DC,Simon B,Fujii SI,Shimizu K,Uslu U,Schuler G,Gerer KF,Hoyer S,Dörrie J,Schaft N

    更新日期:2017-08-17 00:00:00

  • Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma.

    abstract:BACKGROUND:The present study evaluated the expression of hepcidin mRNA in hepatocellular carcinoma (HCC). METHODS:Samples of cancerous and non-cancerous liver tissue were taken from 40 patients with HCC who underwent hepatectomy. Expression of hepcidin mRNA was evaluated by real-time PCR, and compared in tumors differ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-167

    authors: Kijima H,Sawada T,Tomosugi N,Kubota K

    更新日期:2008-06-09 00:00:00

  • Functional characterization of E- and P-cadherin in invasive breast cancer cells.

    abstract:BACKGROUND:Alterations in the cadherin-catenin adhesion complexes are involved in tumor initiation, progression and metastasis. However, the functional implication of distinct cadherin types in breast cancer biology is still poorly understood. METHODS:To compare the functional role of E-cadherin and P-cadherin in inva...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-74

    authors: Sarrió D,Palacios J,Hergueta-Redondo M,Gómez-López G,Cano A,Moreno-Bueno G

    更新日期:2009-03-03 00:00:00

  • Health-related quality of life as an endpoint in oncology phase I trials: a systematic review.

    abstract:BACKGROUND:Phase I trials aim to identify the recommended dose for further development. Health-related quality of life (HRQoL) could be a complement to the usual National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) scale to detect adverse events and define the doses. The objective of thi...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-019-5579-3

    authors: Fiteni F,Ray IL,Ousmen A,Isambert N,Anota A,Bonnetain F

    更新日期:2019-04-16 00:00:00

  • In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.

    abstract:BACKGROUND:Aberrant methylation is a frequent event in oral cancer. METHODS:In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cel...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4077-3

    authors: Pereira CM,de Carvalho AC,da Silva FR,Melendez ME,Lessa RC,Andrade VCC,Kowalski LP,Vettore AL,Carvalho AL

    更新日期:2018-02-17 00:00:00

  • The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study.

    abstract:BACKGROUND:Comorbidity has a well documented detrimental effect on cancer survival. However it is difficult to disentangle the direct effects of comorbidity on survival from indirect effects via the influence of comorbidity on treatment choice. This study aimed to assess the impact of comorbidity on colon cancer patien...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-116

    authors: Sarfati D,Hill S,Blakely T,Robson B,Purdie G,Dennett E,Cormack D,Dew K

    更新日期:2009-04-20 00:00:00

  • Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance.

    abstract:BACKGROUND:Ovarian carcinoma is a rarely curable disease, for which new treatment options are required. As agents that block HMG-CoA reductase and the mevalonate pathway, the statin family of drugs are used in the treatment of hypercholesterolemia and have been shown to trigger apoptosis in a tumor-specific manner. Rec...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-103

    authors: Martirosyan A,Clendening JW,Goard CA,Penn LZ

    更新日期:2010-03-18 00:00:00

  • Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer.

    abstract:BACKGROUND:To assess the diagnostic value of retrospective PET-MRI fusion and to compare the results with side-by-side analysis and single modality use of PET and of MRI alone for locoregional tumour and nodal staging of head-and-neck cancer. METHODS:Thirty-three patients with head-and-neck cancer underwent preoperati...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-846

    authors: Loeffelbein DJ,Souvatzoglou M,Wankerl V,Dinges J,Ritschl LM,Mücke T,Pickhard A,Eiber M,Schwaiger M,Beer AJ

    更新日期:2014-11-19 00:00:00

  • Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.

    abstract:BACKGROUND:Recruitment of cofactors in the interaction of the androgen receptor (AR) and AR ligands plays a critical role in determining androgenic/antiandrogenic effects of the AR ligand on signaling, but the functions of key cofactors, including nuclear receptor coactivator (NCOA), remain poorly understood in prostat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2378-y

    authors: Takeda K,Hara N,Nishiyama T,Tasaki M,Ishizaki F,Tomita Y

    更新日期:2016-05-25 00:00:00

  • Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.

    abstract:BACKGROUND:Oncogene amplification and overexpression occur in tumor cells. Amplification status may provide diagnostic and prognostic information and may lead to new treatment strategies. Chromosomal regions 8p12, 8q24, 11q13, 17q12 and 20q13 are recurrently amplified in breast cancers. METHODS:To assess the frequenci...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-245

    authors: Letessier A,Sircoulomb F,Ginestier C,Cervera N,Monville F,Gelsi-Boyer V,Esterni B,Geneix J,Finetti P,Zemmour C,Viens P,Charafe-Jauffret E,Jacquemier J,Birnbaum D,Chaffanet M

    更新日期:2006-10-13 00:00:00

  • Seeking healthcare at their 'right' time; the iterative decision process for women with breast cancer.

    abstract:BACKGROUND:About 85% of breast cancer patients attending Komfo Anokye Teaching Hospital (KATH), Ghana, present with stage III/IV disease. In spite of great investments into the early diagnosis and management of breast cancer, late presentation persists and poses a barrier to realising the possible benefits of the gains...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07520-x

    authors: Agbeko AE,Arthur J,Bayuo J,Kaburi BB,Kyei I

    更新日期:2020-10-19 00:00:00

  • Application of ultrasound artificial intelligence in the differential diagnosis between benign and malignant breast lesions of BI-RADS 4A.

    abstract:BACKGROUND:The classification of Breast Imaging Reporting and Data System 4A (BI-RADS 4A) lesions is mostly based on the personal experience of doctors and lacks specific and clear classification standards. The development of artificial intelligence (AI) provides a new method for BI-RADS categorisation. We analysed the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07413-z

    authors: Niu S,Huang J,Li J,Liu X,Wang D,Zhang R,Wang Y,Shen H,Qi M,Xiao Y,Guan M,Liu H,Li D,Liu F,Wang X,Xiong Y,Gao S,Wang X,Zhu J

    更新日期:2020-10-02 00:00:00

  • Effects of young age at presentation on survival in breast cancer.

    abstract:BACKGROUND:Young age remains a controversial issue as a prognostic factor in breast cancer. Debate includes patients from different parts of the world. Almost 50% of patients with breast cancer seen at the American University of Beirut Medical Center (AUBMC) are below age 50. METHODS:We reviewed 1320 patients seen at ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-194

    authors: El Saghir NS,Seoud M,Khalil MK,Charafeddine M,Salem ZK,Geara FB,Shamseddine AI

    更新日期:2006-07-20 00:00:00

  • Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry.

    abstract:BACKGROUND:Gastrointestinal stromal tumors (GIST), one of the most common mesenchymal tumors of the gastrointestinal tract, prior to routine immunohistochemical staining and the introduction of tyrosine kinase inhibitors, were often mistaken for neoplasms of smooth muscle origin such as leiomyomas, leiomyosarcomas or l...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-90

    authors: Call J,Walentas CD,Eickhoff JC,Scherzer N

    更新日期:2012-03-19 00:00:00

  • The role of major duct excision and microdochectomy in the detection of breast carcinoma.

    abstract:BACKGROUND:The association of nipple discharge with breast carcinoma has resulted in numerous women undergoing exploratory surgery to exclude malignancy. The aim of this study was to determine whether pre-operative factors can identify those patients that are most at risk of carcinoma. METHODS:All patients over a 14-y...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-164

    authors: Dillon MF,Mohd Nazri SR,Nasir S,McDermott EW,Evoy D,Crotty TB,O'Higgins N,Hill AD

    更新日期:2006-06-23 00:00:00

  • Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.

    abstract:BACKGROUND:Colorectal cancer (CRC) patients with metastatic disease can become cured if neoadjuvant treatment can enable a resection. The search for predictive biomarkers is often performed on primary tumours tissue. In order to assess the effectiveness of tailored treatment in regard to the primary tumour the differen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4639-4

    authors: Mogensen MB,Rossing M,Østrup O,Larsen PN,Heiberg Engel PJ,Jørgensen LN,Hogdall EV,Eriksen J,Ibsen P,Jess P,Grauslund M,Nielsen HJ,Nielsen FC,Vainer B,Osterlind K

    更新日期:2018-07-20 00:00:00

  • CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.

    abstract:BACKGROUND:Patients suffering from squamous cell carcinoma of the larynx (LSCC) with lymphatic metastasis have a relatively poor prognosis and often require radical therapeutic management. The mechanisms which drive metastasis to the lymph nodes are largely unknown but may be promoted by a pro-angiogenic tumor microenv...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4180-5

    authors: Schlüter A,Weller P,Kanaan O,Nel I,Heusgen L,Höing B,Haßkamp P,Zander S,Mandapathil M,Dominas N,Arnolds J,Stuck BA,Lang S,Bankfalvi A,Brandau S

    更新日期:2018-03-09 00:00:00

  • Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure.

    abstract:BACKGROUND:Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer that is thought to be a precursor to most invasive and metastatic breast cancers. Understanding the mechanisms regulating the invasive transition of DCIS is critical in order to better understand how some types of DCIS become invasive. W...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1007-5

    authors: Bischel LL,Beebe DJ,Sung KE

    更新日期:2015-01-21 00:00:00

  • Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder.

    abstract:BACKGROUND:Carcinoma in situ (CIS) is believed to be a precursor of invasive bladder cancer. Identification of CIS is a valuable prognostic factor since radical treatment strategies can be offered these patients before the disease becomes invasive. METHODS:We developed a pathway based classifier approach to predict pr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-37

    authors: Herbsleb M,Christensen OF,Thykjaer T,Wiuf C,Borre M,Orntoft TF,Dyrskjøt L

    更新日期:2008-01-31 00:00:00

  • Impact of organised programs on colorectal cancer screening.

    abstract:PURPOSE:Colorectal cancer (CRC) screening has been shown to decrease CRC mortality. Organised mass screening programs are being implemented in France. Its perception in the general population and by general practitioners is not well known. METHODS:Two nationwide observational telephone surveys were conducted in early ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-104

    authors: Eisinger F,Cals L,Calazel-Benque A,Blay JY,Coscas Y,Dolbeault S,Namer M,Pivot X,Rixe O,Serin D,Roussel C,Morère JF,EDIFICE committee.

    更新日期:2008-04-15 00:00:00

  • Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer.

    abstract:BACKGROUND:The effects of raloxifene, a novel selective estrogen receptor modulator, were studied in a mouse metastatic mammary cancer model expressing cytoplasmic ERα. METHODS:Mammary tumors, induced by inoculation of syngeneic BALB/c mice with BJMC3879luc2 cells, were subsequently treated with raloxifene at 0, 18 an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-566

    authors: Shibata MA,Morimoto J,Shibata E,Kurose H,Akamatsu K,Li ZL,Kusakabe M,Ohmichi M,Otsuki Y

    更新日期:2010-10-19 00:00:00

  • MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma.

    abstract:BACKGROUND:Methylation of promoter region is the major mechanism affecting gene expression in tumors. Recent methylome studies of brain tumors revealed a list of new epigenetically modified genes. Our aim was to study promoter methylation of newly identified epigenetically silenced genes together with already known epi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-218

    authors: Skiriute D,Vaitkiene P,Saferis V,Asmoniene V,Skauminas K,Deltuva VP,Tamasauskas A

    更新日期:2012-06-06 00:00:00

  • Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.

    abstract:BACKGROUND:Renal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find out promising novel biomarkers for effective treatment. The goal of this study was to evaluate the b...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2775-2

    authors: Karim S,Al-Maghrabi JA,Farsi HM,Al-Sayyad AJ,Schulten HJ,Buhmeida A,Mirza Z,Al-Boogmi AA,Ashgan FT,Shabaad MM,NourEldin HF,Al-Ghamdi KB,Abuzenadah A,Chaudhary AG,Al-Qahtani MH

    更新日期:2016-09-30 00:00:00

  • Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review.

    abstract:BACKGROUND:The purpose of this review is to update previously published reviews on exercise programming in exercise trials in prostate cancer survivors. We evaluated: 1) the application of the principles of exercise training in prescribed programs; 2) the reporting of the components of the exercise prescription; and 3)...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5520-9

    authors: Neil-Sztramko SE,Medysky ME,Campbell KL,Bland KA,Winters-Stone KM

    更新日期:2019-04-05 00:00:00